Lightning Health

𝗔𝗿𝗲 𝘆𝗼𝘂 𝗽𝗿𝗲𝗽𝗮𝗿𝗲𝗱 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗝𝗖𝗔? 𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 𝗣𝗜𝗖𝗢𝗦𝗰𝗮𝗻™ The introduction of the European Joint Clinical Assessment (JCA) is the largest development in European market access in the last decade. 💡 In order for the JCA to fulfil its aim of accelerating patient access to new treatments across Europe, the scoping process will be critical to ensure increased transparency and a reduction in the duplication of country level HTA. The starting point for any HTA is defining the PICO: Population, Intervention, Comparators and Outcomes. ⚡ Lightning Health has been closely monitoring how manufacturers will need to prepare in order to navigate the complexity of European healthcare systems to achieve rapid and sustained access. ✅ In response to the introduction of the JCA, we have developed PICOScan™. The PICOScan™ process combines AI search to help you understand the likely PICO requirements for the JCA across EU member states, powered by Lightning Insights. https://lnkd.in/e4bPQMb6 PICOScan™ can help you to avoid the potential challenges associated with multiple PICO requests requiring rapid evidence identification and analytics. ✉ Contact us for more info https://lnkd.in/eSp-RxFG

The Lightning Health team took some time out last week to celebrate 2024. It has been a remarkable year of tremendous growth, and the team has gone above and beyond to support our clients. We are incredibly proud of their commitment to improving patient care and their many achievements both professionally and personally.    Thank you for your continued collaborations with us and we look forward supporting you in 2025.   As with previous years, we haven’t sent cards or gifts, instead we have made a donation to Thames Reach, a London-based charity supporting people facing or experiencing homelessness.   From all the team at Lightning Health, ⚡ Happy Holidays and warm wishes for the New Year ⚡

💡 How will the new EU HTA procedural guidance shape your market access strategy? In this article, Dr Bhakti Dhingra, Senior Analyst at Lightning Health, breaks down the key features of the new guidance and its implications for manufacturers. At Lightning Health, we help manufacturers to make informed decisions to support optimal patient access. Our highly experienced team is dedicated to helping companies navigate the challenges posed by evolving polices. Get in touch at enquiries@lightning.health to discuss how we can support your market access challenges. #eujca #marketaccess #marketresearch #duediligence #healthpolicy

The HTA Coordination Group (HTACG) has adopted nine guidance documents including procedural instructions for Joint Clinical Assessment and Joint Scientific Consultation on medicinal products, as well as templates for briefing documents and scoping processes. At the 11th HTA CG meeting, the group defined the key strategies priorities in the 'Annual Work Programme for 2025'. #europeanhta #eujca #drugpricing #europeancommission #drugassessment #marketaccess

⚡⚡ We are at #ISPOREurope2024 ⚡⚡ ➡️ Our colleague Abigail Williams-Adewole is currently presenting research that delves into the challenges and opportunities for evaluating disease-modifying therapies targeting Alzheimer’s disease across various health technology assessment bodies. Abbie is live on our feed to answer any questions about this interesting research. 💬💬 To meet with the team drop us a line enquiries@lightning.health or DM them directly... Andrew Satherley, James Whitehouse, Nick Stringfellow and Abigail Williams-Adewole #stakeholderresarch #payers #hta #drugpricing #alzheimersdisease #diseasemodifyingtherapies

Our PICOScan™ process combines AI search to help you understand the likely PICO requirements for the JCA across EU member states, powered by Lightning Insights. PICOScan™ can help you to avoid the potential challenges associated with multiple PICO requests requiring rapid evidence identification and analytics. Contact us for more info enquiries@lightning.health https://lnkd.in/e4bPQMb6

The MHRA has set out its plans for the new Innovative Licensing and Access Pathway (ILAP) in England, Scotland and Wales with the aims of accelerating the time to patient care for transformative new medicines, facilitating patient access

Did you know our global stakeholder network is formed of expert advisors from across 4️⃣1️⃣ countries?! From payers and KOLs to patient groups, the Lightning Insights community provides on-demand real world insights to help inform your product development and business strategies. To learn more about our network and services, get in touch! ✉️enquiries@lightning.health #stakeholdernetwork #marketresearch #marketaccess #payer #clinican #patientadvocate #patientgroup

👉 👉 Are you going to #ISPOREurope2024? 👈 👈 👥 Contact Andrew Satherley, James Whitehouse, Abigail Williams-Adewole or Nick Stringfellow directly or via enquiries@lightning.health to arrange a meeting at the conference. #stakeholderinsights #marketaccess #picoscan #healtheconomics #drugpricing

📢 We are hiring! 📢 We are looking for a number of Analysts/Senior Analysts to join our dynamic consultancy team. This is an ideal position for someone looking to begin their career in life sciences or a graduate seeking their first role in market access. For more info 👉 https://lnkd.in/eWmge3Mr To apply ✉️ email your CV and covering letter to careers@lightning.health